Quest Diagnostics Incorporated is a provider of diagnostic information services. It provides diagnostic insights from the results of its laboratory testing to empower people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and its connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. Its other customers include health plans, employers, emerging retail healthcare providers, government agencies, and others. Its services are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.
Company Information
About this company
Key people
James E. Davis
Chairman of the Board, President, Chief Executive Officer
Luis A. Diaz
Independent Director
Tracey C. Doi
Independent Director
Vicky B. Gregg
Independent Director
Sam A. Samad
Chief Financial Officer, Executive Vice President
Catherine T. Doherty
Executive Vice President - Regional Businesses
Michael E. Prevoznik
Senior Vice President, General Counsel
Mark E. Delaney
Senior Vice President, Chief Commercial Officer
Karthik Kuppusamy
Senior Vice President - Clinical Solutions
Patrick T. Plewman
Senior Vice President - Diagnostic Services
Timothy M. Ring
Lead Independent Director
Robert B. Carter
Independent Director
Click to see more
Key facts
- Shares in issue161.70m
- EPICDGX
- ISINUS74834L1008
- LocationUnited States
- SectorHealthcare
- IndustryHealthcare Facilities
- Market cap$21.08bn
- Employees46,000
- ExchangeNew York Stock Exchange
- IndexS&P 500, TR Equity United States Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.